Dr. Kim earned his undergraduate degree from Yale University and his MD from Harvard Medical School. After his internship and residency at Massachusetts General Hospital and fellowships at MGH and Harvard Medical School, he joined the faculty at Harvard where he is currently Assistant Professor of Medicine.
Dr. Kim is the Director of the Viral Hepatitis Clinic within the Division of Infectious Diseases at MGH and focuses his clinical and research interests on special populations with HCV, including those with HIV-1/HCV coinfection, acute HCV, and in the prison population. His research interests are related to these special populations and the immunology of HCV. He is currently serving as a member of the ACTG Hepatitis Transformative Science Group and co-chair of the AASLD / IDSA Guidance Panel for Recommendations for Testing, Managing, and Treating Hepatitis C. He is a Fellow of the Infectious Disease Society of America. He has made numerous presentations related to HCV locally, nationally and abroad.